Log in to save to my catalogue

Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Ge...

Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Ge...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2196524080

Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial

About this item

Full title

Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial

Publisher

New York: Springer US

Journal title

Breast cancer research and treatment, 2019-06, Vol.175 (3), p.627-635

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose
In high-risk early breast cancer, adjuvant taxane-Gemcitabine combinations result in a recurrence-free survival similar to single-agent taxanes. However, haematologic toxicities and need for dose reductions are more frequent in combinations. Which option ultimately provides a better quality of life (QoL) is unknown. We compared the QoL c...

Alternative Titles

Full title

Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2196524080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2196524080

Other Identifiers

ISSN

0167-6806

E-ISSN

1573-7217

DOI

10.1007/s10549-019-05171-6

How to access this item